http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Md. Rakibul Hassan Bulbul,Md. Atiar Rahman,Md. Zillur Rahman,Talha Bin Emran,Mirola Afroze,Mala Khan,Muhammad Abid Hasan Chowdhury,Mohammed Auwal Ibrahim,Mohammed Sohel Chowdhury 경희대학교 융합한의과학연구소 2020 Oriental Pharmacy and Experimental Medicine Vol.20 No.1
This study investigated the restorative effect of Leea macrophylla ethanol root extract (LMERE) in carbon tetrachloride (CCl4) induced hepatic injury. It also tried to unfold the underlying mechanism through ligand-receptor interactions. Prior to conduct the CCl4 induced animal model study, the in vitro antioxidative capacities of LMERE were investigated. Gas chromatography mass spectroscopy (GC–MS) was accomplished to identify the prevalent bioactive compounds. The molecular docking was performed using Schrödinger Suites 2017-1. Results showed the promising antioxidative potentials of LMERE in in vitro models. Upon treatment of CCl4 intoxicated animals with LMERE, serum ALT and AST were found to be significantly (p < 0.05) reduced compared to the CCl4 control while LMERE50 was noted as the best dose in restoring the hepatic markers. Serum lipids and total protein were significantly restored compared to control. Remarkable changes of cell necrosis, apoptosis and sinusoidal dilution were noticed in histopathological assay of liver tissue. mRNA expression for superoxide dismutase (SOD1) and catalase was multifold increased which are statistically significant compared to reference drug, silymarin. In docking study, octadecanoic acid showed the lowest binding energy and highest binding affinity with the protein (ID: 1VKX) which is a crystallized structure of NF-κB p50/p65 heterodimer involved in cytokine production. The findings demonstrate that LMERE restores the hepatic damage by the mRNA expression of antioxidative enzymes while LMERE50, at a glance, seems the most suitable dose.
Proteome Analysis in Adipose Tissue of ob/ob Mice in Response to Chitosan Oligosaccharides Treatment
Rahman, Md. Atiar,Kumar, Suresh G.,Yun, Jong-Won 한국생물공학회 2010 Biotechnology and Bioprocess Engineering Vol.15 No.4
Adipose tissue plays a central role in the development of obesity, and thus characterization of the molecular changes related to obesity in this tissue is a main concern. Recently we identified chitosan oligosaccharides (CO) as a potent adipogenic inhibitor in 3T3-L1 cells. In the current study, a proteomic approach was used to investigate the anti-obesity effect of CO in white adipose tissue of ob/ob mice. CO administration significantly lowered body weight gain and epididymal WAT mass compared to control animals. In addition, twenty-five proteins were found to be differentially expressed between the two groups of animals in response to CO treatment. Expression changes in Karyopherin beta 1, indoleamine-pyrrole 2,3-dioxygenase, and retinoic acid binding protein were associated here for the first time with obesity. Immunoblotting studies of adipocyte protein 2 (aP2) and aquaporin-7 also showed amelioration in their levels in WAT. Furthermore, the results of adipose tissue specific gene expressions of aP2, adiponectin, TNF-${\alpha}$, and IL-6 were in good agreement with improved levels of obesity. Gene expression of PPARg and SREBP-1c were also down-regulated by CO treatment. The results suggest that the anti-obesity effect of CO might be mediated by the modulation of adipokines and adipose tissue specific genes.
Kumar, Suresh G.,Rahman, Md. Atiar,Lee, Sung Hak,Hwang, Hee Sun,Kim, Hyun Ah,Yun, Jong Won WILEY-VCH Verlag 2009 Proteomics Vol.9 No.8
<P>Altered levels of adipokines, derived as a result of distorted adipocytes, are the major factors responsible for changing biochemical parameters in obesity that leads to the development of metabolic disorders such as insulin resistance and atherosclerosis. In our previous reports, chitosan oligosaccharides (CO) were proved to inhibit the differentiation of 3T3-L1 adipocytes. In the present study, an attempt was made to investigate the anti-obesity and anti-diabetic effect of CO on ob/ob mice, by means of differential proteomic analysis of plasma. This was followed by immunoblotting, and gene expression in adipose tissue to clarify the molecular mechanism. CO treatment showed reduced diet intake (13%), body weight gain (12%), lipid (29%) and glucose levels (35%). 2-DE results showed differential levels of five proteins namely RBP4, apoE, and apoA-IV by >2-fold down-regulation and by >2-fold of apoA-I and glutathione peroxidase (GPx) up-regulation after CO treatment. Immunoblotting studies of adiponectin and resistin showed amelioration in their levels in plasma. Furthermore, the results of gene expressions for adipose tissue specific TNF-α, and IL-6 secretary molecules were also down-regulated by CO treatment. Gene expressions of PPARγ in adipose tissue were in good agreement with the ameliorated levels of adipokines, thereby improving the pathological state. Taken together, CO might act as a potent down-regulator of obesity-related gene expression in ob/ob mice that may normalize altered plasma proteins to overcome metabolic disorders of obesity.</P>
윤종원,Hye Jin Hwang,Sang Woo Kim,Yu Mi Baek,Sung Hak Lee,Hee Sun Hwang,Suresh G. Kumar,Md. Atiar Rahman 한국화학공학회 2008 Korean Journal of Chemical Engineering Vol.25 No.2
We investigated the influence of hypoglycemic fungal extracellular polysaccharides (EPS) on the differential expression of liver proteins in streptozotocin (STZ)-induced diabetic rats. The results of diabetic study revealed that orally administrated EPS exhibited an excellent hypoglycemic effect, lowering the average plasma glucose level in EPS-fed rats to 55.1% with enhanced glucose tolerance. In the next step, we analyzed the differential expression patterns of rat liver proteins from each group to discover potent candidates for diabetes-associated proteins. 34 proteins were upregulated and 35 proteins were downregulated upon diabetes induction. Surprisingly, the altered levels of most proteins in the diabetic group were fully or partially restored to those of the non-diabetic control group by EPS treatment. Although the molecular basis of protein modulation after EPS administration in diabetic rats was not verified, the results of the proteomic analysis provide impetus for further studies to identify reliable biomarkers for diabetic therapy.